Healthequity (HQY) EV to EBITDA (2014 - 2026)

Healthequity has reported EV to EBITDA for 13 years, with the latest figure at 81.93 in Q3 2026.

• On a quarterly basis, EV to EBITDA fell 9.12% year-over-year to 81.93 in Q3 2026; TTM through Jul 2026 was 23.01, a 33.22% decrease from a year earlier, with the FY2026 full-year figure at 21.6, down 62.14% from the prior year.
• EV to EBITDA was 81.93 for Q3 2026 at Healthequity, up from 64.29 in the prior quarter.
• The five-year high for EV to EBITDA was 1151.89 in Q4 2022, with the low at 1965.17 in Q3 2022.
• Average EV to EBITDA over 5 years is 43.57, with a median of 110.75 recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: EV to EBITDA sank 153.13% in 2022, then jumped 337.78% in 2023.
• Over 5 years, EV to EBITDA stood at 1151.89 in 2022, then tumbled by 83.65% to 188.28 in 2023, then jumped by 91.6% to 360.74 in 2024, then slumped by 72.57% to 98.97 in 2025, then slipped by 17.22% to 81.93 in 2026.
• The last three EV to EBITDA figures came in at 81.93 (Q3 2026), 64.29 (Q2 2026), and 97.98 (Q1 2026), per Business Quant data.